Procter & Gamble Health Share Price
Small Cap | Pharmaceuticals and health care | NSE: PGHL | BSE: 500126
₹5,222.25 
-78.85 (-1.49 %)
Last Updated: 04 Apr 2025 03:48 PM
BEARISH
Overview
Open (₹) 5,300.20
High (₹) 5,307.00
Low (₹) 5,175.00
Prev. Close (₹) 5,301.10
Volume 4,390
VWAP (₹) 5,070.18
ROCE (%) 51.13
Industry P/E 44.73
TTM P/E 36.64
P/B Ratio 16.11
Market Cap (₹) Cr.8,668.61
Dividend Yield (%)4.98
EPS (₹) 121.00
ROE37.32%
Sales Growth (%) -6.37
Profit Growth (%)-12.42
Day Range
5,307.005,307.00
52 Week Range
4,640.305,835.95
Historical Returns
Returns (6M)
-0.21 %
Returns (1Y)
9.64 %
Returns (3Y)
18.75 %
Returns (5Y)
20.63 %
Returns (6M)
-0.21 %
Returns (1Y)
9.64 %
Returns (3Y)
18.75 %
Returns (5Y)
20.63 %
SWOT Analysis
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 47.45
MFI 61.86
ATR 195.14
Commodity Channel Index -230.45
ROC125 -3.34
ROC21 -4.85
Williams %R -79.84
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 5,308.25 | 5,582.45 | 5,776.50 | 5,114.20 | 4,840.00 | 4,645.95 | 4,371.75 |
| Week Ago | 5,320.06 | 5,364.53 | 5,414.06 | 5,270.53 | 5,226.06 | 5,176.53 | 5,132.06 |
| Month Ago | 5,298.30 | 5,354.10 | 5,420.75 | 5,231.65 | 5,175.85 | 5,109.20 | 5,053.40 |
EMA & SMA
5222.25
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 5249.05
9 Day 5276.93
10 Day 5261.93
12 Day 5275.30
14 Day 5287.88
20 Day 5312.17
26 Day 5312.30
50 Day 5323.70
100 Day 5310.74
200 Day 5211.41
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 03 Oct, 2022 | ₹4,106.95 | 6,405 | NSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹4,106.95 | 44,711 | NSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 03 Oct, 2022 | ₹4,106.95 | 6,405 | NSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹4,106.95 | 44,711 | NSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 31 Jan, 2025 | Rs.80.0000 per share(800%)Interim Dividend | 21 Feb, 2025 | 21 Feb, 2025 |
| 22 Aug, 2024 | Rs.60.0000 per share(600%)Final Dividend | 28 Nov, 2024 | 01 Jan, 1970 |
| 26 Jan, 2024 | Rs.150.0000 per share(1500%)Special Dividend | 14 Feb, 2024 | 14 Feb, 2024 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 26 Mar, 2025 | NSE India | Procter & Gamble Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 26 Mar, 2025 | NSE India | Procter & Gamble Health Limited has informed the Exchange about Closure of Trading Window |
| 26 Mar, 2025 | NSE India | PROCTER & GAMBLE HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend. |
| 26 Mar, 2025 | BSE India | Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 29, 2025, inter alia, to consider and approve Audited Financial Statements for the Financial Year ended March 31, 2025 and to consider recommendation of dividend (if any). |
| 10 Mar, 2025 | NSE India | Procter & Gamble Health Limited has informed the Exchange regarding Notice of Postal Ballot |
| 10 Mar, 2025 | BSE India | Dear Sir,\r\n\r\nPlease find attached notice of postal ballot along with postal ballot form, for seeking approval of the members of the Company on the agenda items mentioned in the postal ballot notice. |
| 18 Feb, 2025 | NSE India | Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, we are submitting herewith the Integrated Filing (Financial) for the quarter and six months ended December 31, 2024 |
| 18 Feb, 2025 | BSE India | Dear Sir,\r\n\r\nPursuant to SEBI circular dated December 31, 2024, we are hereby submitting integrated financial filing for the quarter and half year ended December 31, 2024. \r\n\r\nRequest you to kindly take note of the same. |
| 17 Feb, 2025 | NSE India | Unaudited Financial Results for the quarter ended December 31, 2024 and Interim Dividend for Financial Year 2024-25 |
| 13 Feb, 2025 | NSE India | Procter & Gamble Health Limited has informed the Exchange regarding ''Communication on TDS on dividend income declared by the Company''. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Audited Results & Final Dividend | -- | 28 Mar, 2025 | 29 May, 2025 |
| Quarterly Results & Interim Dividend | -- | 01 Feb, 2025 | 12 Feb, 2025 |
| Quarterly Results | -- | 01 Oct, 2024 | 04 Nov, 2024 |
| Audited Results & Final Dividend | -- | 01 Jul, 2024 | 21 Aug, 2024 |
| Quarterly Results | -- | 01 Apr, 2024 | 02 May, 2024 |
| Quarterly Results & Interim Dividend | -- | 15 Jan, 2024 | 06 Feb, 2024 |
| Quarterly Results | -- | 28 Sept, 2023 | 03 Nov, 2023 |
| Audited Results & Final Dividend | -- | 18 Jul, 2023 | 23 Aug, 2023 |
| Quarterly Results | -- | 25 Apr, 2023 | 15 May, 2023 |
| Quarterly Results & Interim Dividend | -- | 18 Jan, 2023 | 08 Feb, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| Foreign Institutions + | 6.61% | 7.6% | 6.33% | 5.97% | 6.15% |
| Domestic Institutions + | 14.84% | 12.66% | 12.44% | 8.53% | 11.72% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 26.73% | 27.92% | 29.41% | 33.68% | 30.31% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Procter & Gamble Health
Procter & Gamble Health is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1151.26 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2024.
Parent Organisation
MNC Associate
Founded
1967
Managing Director
Mr. Milind Thatte
NSE Symbol
PGHL
Procter & Gamble Health Management
| Name | Designation |
|---|---|
| Mr. Suresh Talwar | Chairman & Ind.Director |
| Mr. Milind Thatte | Managing Director |
| Mr. Lokesh Chandak | Executive Director & CFO |
| Ms. Seema Sambasivan | Non Executive Director |
| Mr. Aalok Agrawal | Non Executive Director |
| Mrs. Rani Jadhav | Independent Director |
| Mr. S Madhavan | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35  ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
| Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50  ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Procter & Gamble Health
What is the share price of Procter & Gamble Health?
The share price of Procter & Gamble Health on 04 Apr, 2025 is ₹ 5,222.25.
What is 52W high and 52W low share price of Procter & Gamble Health?
The highest and lowest 52W share prices of Procter & Gamble Health are ₹ 5835.950 and ₹ 4640.300
What is the market cap of Procter & Gamble Health?
The market capitalization of Procter & Gamble Health as of 04 Apr, 2025 is ₹ 8,668.61 Crores
What is the P/E ratio of Procter & Gamble Health?
The current P/E ratio of Procter & Gamble Health as of 04 Apr, 2025 is 44.73
What is the PB ratio of Procter & Gamble Health?
The PB ratio of Procter & Gamble Health as of 04 Apr, 2025 is 16.11
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)